Free Trial

Theratechnologies (TSE:TH) Stock Price Passes Above 50 Day Moving Average - Here's Why

Theratechnologies logo with Medical background

Theratechnologies Inc. (TSE:TH - Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$2.52 and traded as high as C$3.97. Theratechnologies shares last traded at C$3.74, with a volume of 273,150 shares trading hands.

Analyst Upgrades and Downgrades

TH has been the subject of a number of research analyst reports. Research Capitl upgraded shares of Theratechnologies to a "strong-buy" rating in a research note on Friday, February 14th. Jones Trading raised shares of Theratechnologies from a "hold" rating to a "strong-buy" rating in a research report on Friday, April 11th.

Check Out Our Latest Research Report on Theratechnologies

Theratechnologies Stock Performance

The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of -293.92. The stock has a 50 day simple moving average of C$2.52 and a 200 day simple moving average of C$2.25. The company has a market capitalization of C$119.33 million, a price-to-earnings ratio of -42.34, a P/E/G ratio of -8.50 and a beta of 1.73.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Theratechnologies Right Now?

Before you consider Theratechnologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.

While Theratechnologies currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines